|Diet|| Weight Loss
| ||An obese woman who has ovarian cancer is more likely to die from it than a woman of normal weight who also has ovarian cancer, say scientists from the The Cedars-Sinai Medical Center, USA. They say that fat cells encourage tumour growth by excreting a hormone.|
The scientists concluded that obesity (for women with ovarian cancer):
Undermines a woman's survival rate.
Made recurrence after treatment more likely and earlier.
Made women die earlier. [Cancer DOI: 10.1002/cncr.22194 Aug 2006]
Conventional Drugs / Information
| ||Introducing chemotherapy directly into the abdomen, instead of into veins as is usually done, can be more effective. This allows physicians to expose the area surrounding the tumor to higher concentrations of medicine, while normal tissues, such as bone marrow, are spared.|
Patients who choose the therapy, however, may pay a price for a longer life: Study participants who had the medicines dripped into their abdominal cavities, called intraperitoneal therapy, suffered more severe and more frequent side effects during and right after treatment, including infections, stomach pain, and numbness and tingling in their fingers and toes. Just 42% of the 205 women started on the therapy were able to withstand the 18 weeks of treatment. [NEJM Jan 5, 2006]
| ||Christine Sable was not diagnosed with ovarian cancer until it was already advanced; a scenario far too common with this particular type of cancer. |
After enduring surgery and an aggressive round of chemotherapy, doctors had nothing else to offer her but more chemotherapy. Instead, Sable sought out, and in 2004 was accepted into, a Phase I clinical research study of an ovarian cancer vaccine developed by Kunle Odunsi, MD, PhD, Surgeon in Gynecologic Oncology and Co-Leader of the Tumor Immunology and Immunotherapy Program at Roswell Park Cancer Institute in Buffalo, New York.
According to a report in ScienceDaily, the vaccine "is designed to trigger an immune response in the significant number of women who have tumors that test positive for the antigen NY-ESO-1."
The report states that Sable's immune system "responded so strongly to the first five doses of vaccine that she received another five, then another five, each time experiencing a better responseŚwith no side effects. Now 49 and still cancer-free, she returns to Roswell Park just once a year for continued monitoring." [ScienceDaily Apr. 7, 2008]
LDN - Low Dose Naltrexone
| ||Dr. Bihari reports some success using LDN on ovarian cancers.|
| ||See the link between Cancer (General) and Hydrazine Sulfate.|
Diindolylmethane DIM / Indole 3 Carbinol IC3
| ||We all know that eating fruits, vegetables and soy products provides essential nutrition for a healthy lifestyle, while obesity leads to the opposite. Yet proving the effect of nutrition, or obesity, on cancer is an experimental challenge and a focus for scientists. According to emerging evidence being presented at the 2007 Annual Meeting of the American Association for Cancer Research, eating well might still be one of the more pleasurable ways to prevent cancer and promote good health.|
Eating such foods as broccoli and soy are believed to offer some protection against cancer, but how this occurs is not well-understood. Now, in laboratory experiments, researchers at the University of California, Los Angeles, have discovered a biological mechanism whereby two compounds in these foods might lower the invasive and metastatic potential of breast and ovarian cancer cells.
They found that diindolylmethane (DIM), a compound resulting from digestion of cruciferous vegetables, and genistein, a major isoflavone in soy, reduce production of two proteins whose chemotactic attraction to each other is necessary for the spread of breast and ovarian cancers.
When applying purified versions of diindolylmethane and genistein to motile cancer cells, the researchers could literally watch these cells come to a near halt. When either compound was applied, migration and invasion were substantially reduced.
"We think these compounds might slow or prevent the metastasis of breast and ovarian cancer, which would greatly increase the effectiveness of current treatments," said Erin Hsu, a graduate student in molecular toxicology. "But we need to test that notion in animals before we can be more definitive."
Both DIM (diindolylmethane) and genistein are already being developed for use as a preventive and a chemotherapy treatment for breast cancer, although more extensive toxicological studies are necessary, the researchers say.